Molecular Pathology, Diagnostics, and Therapeutics
A section of International Journal of Molecular Sciences (ISSN 1422-0067).
Section Information
This section of the International Journal of Molecular Sciences (IJMS) aims to enable rapid publication of contributions on all aspects of molecular pathology, ranging from basic research at the molecular level, to clinical and forensic applications. We welcome studies on molecular mechanisms, diagnostics, and therapeutics of human disease and relevant experimental models using cellular, molecular, biological, chemical and immunological approaches. Topics include, but are not limited to:
- the molecular and cellular mechanism of diseases and injury
- immunopathology and diseases
- mechanisms of immunotoxicity
- matrix pathobiology
- in vitro and in vivo aspects of inflammation and autophagy
- mechanism of tissue alterations
- mechanisms of genotoxicity
- musculoskeletal pathology
- molecular diagnostics
- molecular targeted therapy
- cell injury, repair, aging and apoptosis
- stem cell or gene therapy
- novel mechanisms of carcinogenesis
- application of molecular pathology to tissue identification
We also welcome reviews on these subjects, particularly those that challenge existing concepts.
Keywords
Cardiovascular disease; pneumonia; kidney; cardiotoxicity of non-cardiac drugs; mitochondria; gastrointestinal tract, hepatobiliary and pancreas; B and T-cell; infectious diseases; inflammation; immunotoxicity; tissue alterations; metabolism, endocrine and urogenital; genotoxicity; musculoskeletal; pharmacogenomics; gene therapy; stem cells; DNA damaging; cancer; atherosclerosis; endothelium
Editorial Board
Topic Board
Special Issues
Following special issues within this section are currently open for submissions:
- Molecular Mechanisms Regulating Osteoclastogenesis 2.0 (Deadline: 15 May 2021)
- Adipokines, Myokines and Physical Exercise in Health and Disease (Deadline: 15 May 2021)
- Molecular Pathogenesis of Neurodegenerative Diseases Targeting Early Diagnosis and Treatment (Deadline: 15 May 2021)
- Lymphangiogenesis in Development and Disease—Taking a Fresh Look at the Forming Lymphatics (Deadline: 15 May 2021)
- Mechanisms of Phosphate Transport (Deadline: 15 May 2021)
- Pro-inflammatory and Anti-inflammatory Cytokines in Autoimmune Diseases (Deadline: 16 May 2021)
- Molecular Research in Multiple Sclerosis (Deadline: 25 May 2021)
- Pro-inflammatory Nutrient: Focus on Gliadin and Celiac Disease (Deadline: 30 May 2021)
- Retinal Function and Morphology in Health, Aging and Disease (Deadline: 31 May 2021)
- Mitochondrial Coenzyme Q (Deadline: 31 May 2021)
- Pathomechanisms of Atherosclerosis. Part III (Deadline: 31 May 2021)
- Infections, Inflammation and Neurodegeneration in Alzheimer's Disease (Deadline: 31 May 2021)
- Study on Gene Identification and Gene Function in Multiple Sclerosis (Deadline: 31 May 2021)
- Recent Advances in Intermediate Filaments (Deadline: 31 May 2021)
- Aging and Senescence (Deadline: 31 May 2021)
- Heart Failure: From Molecular Basis to Therapy 2.0 (Deadline: 31 May 2021)
- Musculoskeletal Development and Skeletal Pathophysiologies (Deadline: 31 May 2021)
- Advances in Endothelial Cell Biology (Deadline: 31 May 2021)
- Congenital and Acquired Platelet Disease (Deadline: 31 May 2021)
- Gynecologic Oncology: From Molecular Mechanisms to Targeted Therapies 2.0 (Deadline: 31 May 2021)
- STATs in Cancer Microenvironment (Deadline: 31 May 2021)
- Etio-Pathogenesis and Therapeutic Approaches of Skin Pigmentation Abnormalities (Deadline: 31 May 2021)
- Barrier Function of Skin and Oral Mucosa (Deadline: 31 May 2021)
- Rare Monogenic Diseases: Molecular Pathophysiology and Novel Therapies (Deadline: 31 May 2021)
- Advances in Understanding of Cardiac Arrhythmias for Innovative Treatment (Deadline: 31 May 2021)
- Molecular Biomarkers for Diagnostics and Prognostics in Psychiatric Disorders (Deadline: 31 May 2021)
- Complimentary Medicine for the Treatment of Chronic and Infectious Diseases (Deadline: 31 May 2021)
- Molecular Imaging in Diabetes, Obesity, and Infections 2.0 (Deadline: 31 May 2021)
- Molecular and Functional Aspects of Adult Neurogenesis (Deadline: 31 May 2021)
- The Genetic and Molecular Basis of Congenital Myopathies and Various Rare Diseases (Deadline: 31 May 2021)
- Novel Approaches to Hematologic Malignancies by Immunotherapy (Deadline: 31 May 2021)
- Blood-Derived Products for Tissue Repair/Regeneration 2021 (Deadline: 31 May 2021)
- Functionalized Liposomes (Deadline: 31 May 2021)
- Research of Pathogenesis and Novel Therapeutics in Arthritis 3.0 (Deadline: 31 May 2021)
- Purinergic Signaling in Neuroinflammation (Deadline: 31 May 2021)
- Hepatitis B Virus and Carcinogenesis—Pathophysiology, Disease and Treatment (Deadline: 31 May 2021)
- Lipodystrophy and Fat Redistribution: From Molecular Basis to Therapies (Deadline: 31 May 2021)
- Recent Advances in Salivary Gland and Their Function (Deadline: 31 May 2021)
- Endometriosis and Uterine Fibroids: From Molecular Biology to Therapy (Deadline: 31 May 2021)
- Coronary Syndromes – Advances in Diagnostics and Therapy (Deadline: 31 May 2021)
- Molecular Research on Platelet Activity in Health and Disease 3.0 (Deadline: 31 May 2021)
- Thrombo-Inflammatory Extracellular Vesicles (Deadline: 31 May 2021)
- Hypoxia Signaling in Human Diseases (Deadline: 31 May 2021)
- Molecular Research on Type 1 Diabetes and Its Complications (Deadline: 31 May 2021)
- Molecular Effects of Antimicrobials on Periodontitis (Deadline: 31 May 2021)
- Crosstalk between MicroRNA and Oxidative Stress in Physiology and Pathology 2.0 (Deadline: 1 June 2021)
- The Molecular Mechanism of Gastrointestinal Malignancies: The Path from Genomic Alterations to Tumor Aggressiveness (Deadline: 11 June 2021)
- CAR-T Cell Therapy 2.0 (Deadline: 15 June 2021)
- Sarcopenic Obesity: Mechanisms and Countermeasures (Deadline: 15 June 2021)
- Target Dysfunctional Inflammation in Cystic Fibrosis Airway (Deadline: 15 June 2021)
- Peptide Based Smart Molecules in Regenerative Medicine (Deadline: 15 June 2021)
- Tumor Microenvironment from a Precision Medicine Perspective (Deadline: 15 June 2021)
- Novel Molecular Mechanisms and Pathophysiology of Human Embryos (Deadline: 20 June 2021)
- Cellular and Molecular Mechanisms of Blood–Brain Barrier Dysfunction 2.0 (Deadline: 28 June 2021)
- Metabolic Associated Fatty Liver Disease (MAFLD) Research 2020-2021 (Deadline: 30 June 2021)
- Genetics of Circadian Rhythms and Sleep (Deadline: 30 June 2021)
- Nodal and Cripto-1 Signaling: Re-emergence in Cancer and Biological Role (Deadline: 30 June 2021)
- Biomarker-Oriented Treatment of Urogenital Cancers (Deadline: 30 June 2021)
- Osteoblast Differentiation and Activity in Skeletal Diseases (Deadline: 30 June 2021)
- Advances in Translational Research in Oral Tissue Regeneration (Deadline: 30 June 2021)
- Antimicrobial Peptides and Antimicrobial Chemokines (Deadline: 30 June 2021)
- Tumor Microenvironment and Actin Cytoskeleton in Cancer Cell Metastasis (Deadline: 30 June 2021)
- Amyloid Hetero-Aggregation (Deadline: 30 June 2021)
- Hypertension and Cardiovascular Diseases: From Etiopathogenesis to Potential Therapeutic Targets (Deadline: 30 June 2021)
- Osteoclast Multinucleation Mechanisms 2.0 (Deadline: 30 June 2021)
- TGF-Beta Super Family Signaling 3.0 (Deadline: 30 June 2021)
- Tumour Cell Dissemination in Bone: Pathophysiology and Therapeutic Strategies (Deadline: 30 June 2021)
- Cardiac Repair and Regeneration: New Molecular Mechanisms and Therapeutics (Deadline: 30 June 2021)
- Melatonin in Disease and Health (Deadline: 30 June 2021)
- Molecular Research of Aging Stress Response (Deadline: 30 June 2021)
- Molecular Research on Platelet Function in Disease (Deadline: 30 June 2021)
- Osteoarthritis: From Molecular Pathways to Therapeutic Advances (Deadline: 30 June 2021)
- Proton-Pump Inhibitors (PPIs) 2.0 (Deadline: 30 June 2021)
- Metabolic Disturbances in Hematologic Malignancies (Deadline: 30 June 2021)
- New Frontiers in Molecular Research of Digestive Diseases (Deadline: 30 June 2021)
- Ras Subfamily and Regulators in Human Disease and Repair (Deadline: 30 June 2021)
- Role of Mitochondrial Dysfunction in the Pathogenesis of Cardiovascular Diseases (Deadline: 30 June 2021)
- Pathophysiology of the Serotonin System in the Nervous System and Beyond (Deadline: 30 June 2021)
- Extracellular Vesicles and Tumour Microenvironment 2.0 (Deadline: 30 June 2021)
- Molecular Research On Abdominal Aortic Aneurysm (Deadline: 30 June 2021)
- Cardiovascular Consequence of Acute Kidney Injury, Chronic Kidney Disease and AKI-to-CKD Transition (Deadline: 30 June 2021)
- Atherosclerosis: From Molecular Biology to Therapeutic Perspective (Deadline: 30 June 2021)
- Tumor Immunology & Immunotherapy (Deadline: 30 June 2021)
- Osteoporosis: From Molecular Mechanisms to Therapies 3.0 (Deadline: 30 June 2021)
- Ferroportin and Ceruloplasmin: Structure and Function in Health and Disease (Deadline: 30 June 2021)
- Biomolecular Mediators in Cardiomyopathies (Deadline: 30 June 2021)
- Protective Strategies against Organ Ischemic Injury (Deadline: 30 June 2021)
- Uterine Fibroids: From Molecular Basis to Therapy (Deadline: 30 June 2021)
- High-Density Lipoproteins in Non-cardiovascular Diseases (Deadline: 30 June 2021)
- Estrogens in Human Cancer (Deadline: 30 June 2021)
- Therapeutic Aspects of Gasotransmitters in Cardiovascular and Renal Disease 2.0 (Deadline: 30 June 2021)
- Mechanisms of Cancer Development in Diabetes (Deadline: 30 June 2021)
- Somatic Cell Nuclear Transfer in Embryonic Development and Stem Cell Research (Deadline: 30 June 2021)
- Physio-Pathological Role of ERAD and Its Pharmacological Modulation (Deadline: 30 June 2021)
- Advances in the Pathobiology and Treatment of Hodgkin Lymphoma (Deadline: 30 June 2021)
- Sperm-Egg Adhesion and Fusion (Deadline: 30 June 2021)
- Sleep Apnea and Intermittent Hypoxia 2.0 (Deadline: 1 July 2021)
- Pathobiology of Acute Kidney Injury (Deadline: 1 July 2021)
- Metabolomics in Medicine 2.0 (Deadline: 1 July 2021)
- Hypertension and Cardiovascular Prevention: The Role of Acute and Chronic Inflammation (Deadline: 15 July 2021)
- The Role of Trace Elements in Diseases (Deadline: 15 July 2021)
- Molecular Approach to Obstructive Sleep Apnea Syndrome: Precise Diagnosis and Targeted Treatment (Deadline: 23 July 2021)
- Extracellular Matrix in Development and Disease 3.0 (Deadline: 30 July 2021)
- Molecular Players in Diagnostics and Therapeutics of Malignant Pleural Mesothelioma (Deadline: 31 July 2021)
- Hepatitis Virus Infection and Molecular Research 2021 (Deadline: 31 July 2021)
- RNA Diseases (Deadline: 31 July 2021)
- Active Molecules and Complexes for Neurodegenerative Prevention (Deadline: 31 July 2021)
- Molecular Mechanisms of Cardioprotection (Deadline: 31 July 2021)
- Current Mechanistic Understandings of Lymphedema and Lipedema (Deadline: 31 July 2021)
- Molecular Mechanism of Alzheimer's Disease III (Deadline: 31 July 2021)
- Mechanical and Biochemical Interplay between Cells and Their Microenvironment (Deadline: 31 July 2021)
- Oxidative Stress and Brain Injury 2.0 (Deadline: 31 July 2021)
- Genetics of Eye Disease (Deadline: 31 July 2021)
- Role of Extracellular Vesicles in Tumor Microenvironment (Deadline: 31 July 2021)
- Molecular Mechanisms of Periodontal Disease 2.0 (Deadline: 31 July 2021)
- Cancer Chemoresistance: Novel Mechanistic Insights and Emerging Therapeutic Strategies (Deadline: 31 July 2021)
- Circadian Clock and Reproduction (Deadline: 31 July 2021)
- Molecular and Metabolic Mechanisms of Parkinson's Disease (Deadline: 31 July 2021)
- Molecular Mechanisms of Drug-Induced, Immune-Mediated Liver Injury (Deadline: 31 July 2021)
- Atherosclerotic and Cardiometabolic Disease: From Molecular Basis to Therapeutic Advances (Deadline: 31 July 2021)
- Oxidative Stress and Genotoxicity: New Insights (Deadline: 31 July 2021)
- New Innovations in Wound Healing and Repair 2.0 (Deadline: 31 July 2021)
- Role of Environmental and Metabolic Factors in Inflammatory Bowel Disorders (Deadline: 31 July 2021)
- Impact of Dyslipidemia and Metabolic Syndrome on Cardiac Dysfunction (Deadline: 31 July 2021)
- Role of Extracellular Vesicles Produced by Stem Cells in Tissue Repair (Deadline: 31 July 2021)
- New Insight into Nutrient Response and Adaptation: From Molecular Mechanism to Metabolic Reprogramming (Deadline: 31 July 2021)
- Transcriptional Regulation of Cardiac Development and Disease (Deadline: 31 July 2021)
- Role of G-Protein Coupled Receptors in Cardiovascular Diseases (Deadline: 31 July 2021)
- Mechanisms of Olfactory and Gustatory Sense and Their Regeneration (Deadline: 31 July 2021)
- Chronic Obstructive Pulmonary Diseases (Deadline: 31 July 2021)
- Molecular Research on Stroke Prognosis, Complications, and Therapeutic Effects (Deadline: 31 July 2021)
- Genetic Analysis, Pathogenic Process Deciphering, Drug Development in Parasitic Diseases (Deadline: 31 July 2021)
- Molecular Research on Chronic Fatigue Syndrome (CFS) (Deadline: 31 July 2021)
- Sphingolipids: Metabolic Functions and Disorders 2.0 (Deadline: 31 July 2021)
- Mucopolysaccharidoses: Diagnosis, Treatment, and Management 2.0 (Deadline: 31 July 2021)
- Advances in Molecular Biology and Targeted Therapy of Leukemias 3.0 (Deadline: 31 July 2021)
- Calmodulin Binding Proteins (Deadline: 31 July 2021)
- Inflammation Networks and Chronic Diseases: Molecules and Methods (Deadline: 31 July 2021)
- Muscular Dystrophy: From Molecular Basis to Therapies 2021 (Deadline: 1 August 2021)
- Host-Oral Bacterial Interactions in Periodontal Pathogenesis (Deadline: 1 August 2021)
- Epithelium-Immune Cell Interactions Underlying Innate and Adaptive Immunity (Deadline: 1 August 2021)
- Dry Eye and Ocular Surface Disorders 3.0 (Deadline: 30 August 2021)
- Role for the Enzyme Myeloperoxidase to Elicit Pathologies 2.0 (Deadline: 31 August 2021)
- Targeted Therapies in Cancer: Radionuclides, Multi-Omics and Nanomedicine (Deadline: 31 August 2021)
- Transcription in Cancer Initiation and Progression (Deadline: 31 August 2021)
- Glycoconjugates: Challenges and Opportunities (Deadline: 31 August 2021)
- Vascular Dementia (Deadline: 31 August 2021)
- Molecular and Physiological Determinants of Amyotrophic Lateral Sclerosis (Deadline: 31 August 2021)
- The Diabetic Eye Disease: Mechanisms Underlying Pathophysiology and Therapies 2.0 (Deadline: 31 August 2021)
- New Regulators and Modulators of MicroRNA 2020 (Deadline: 31 August 2021)
- Molecular Pathology, Diagnostics, and Therapeutics of Nephropathy (Deadline: 31 August 2021)
- Advances Research on Pulmonary Hypertension and Right Heart Failure (Deadline: 31 August 2021)
- Autoimmune Arthritis and Inflammatory Bowel Diseases (Deadline: 31 August 2021)
- Melatonin: Molecular Mechanisms and Biological Functions. A 2021 Update (Deadline: 31 August 2021)
- Versatile Stem Cells for Therapeutic Applications (Deadline: 31 August 2021)
- Molecular Mechanisms of Pregnancy-Related Vascular Remodeling and Pregnancy Complications (Deadline: 31 August 2021)
- Flow Cytometry and Its Applications to Molecular Biology and Diagnosis 2.0 (Deadline: 31 August 2021)
- Mammalian Gametes: Molecular Traits Shaping their Form and Fate (Deadline: 31 August 2021)
- Molecular Basis of Sensory Transduction in Health and Disease (Deadline: 31 August 2021)
- Molecular Research on Arteriosclerosis and Thrombosis (Deadline: 31 August 2021)
- Diagnosis, Pathology, and Treatment of Autoimmune Diseases in the Era of Precision Medicine (Deadline: 31 August 2021)
- Application of Bio-Molecular Sciences in Peritoneal Dialysis (Deadline: 31 August 2021)
- Research on Charcot-Marie-Tooth Disease, from Molecules to Therapy 2.0 (Deadline: 31 August 2021)
- Advances in Molecular Studies of Solid Tumors (Deadline: 31 August 2021)
- New Perspectives into the Molecular Pathophysiology and Treatment of Type 2 Diabetes Mellitus (Deadline: 31 August 2021)
- New Advances in Aquaporinopathy (Deadline: 31 August 2021)
- Molecular Pathways in Cardio–Metabolic Disease (Deadline: 31 August 2021)
- Thyroid Hormones and NAFLD: New Insights 2.0 (Deadline: 31 August 2021)
- Antioxidants and Obesity 2.0 (Deadline: 31 August 2021)
- Focus on Gastrointestinal Diseases (Deadline: 31 August 2021)
- Nanoparticles and Their Interactions with Target Cells, Host Receptors and Soluble Factors (Deadline: 31 August 2021)
- Protein Folding Diseases—Molecular Mechanisms and Therapeutic Approaches (Deadline: 31 August 2021)
- Molecular Vascular Physiology (Deadline: 31 August 2021)
- Role of Signaling Pathways in the Viral Life Cycle 2.0 (Deadline: 31 August 2021)
- Oxidative Stress and Skeletal Muscle Function (Deadline: 31 August 2021)
- Molecular Research on Neurodegenerative Diseases 2.0 (Deadline: 31 August 2021)
- Antiviral and Antimicrobial Peptides (Deadline: 31 August 2021)
- Genetic and Metabolic Molecular Research of Lysosomal Storage Disease 2.0 (Deadline: 31 August 2021)
- Programmed Cell Death and Apoptosis 2021 (Deadline: 31 August 2021)
- Molecular Mechanism and Application of Somatic Cell Cloning in Mammals (Deadline: 31 August 2021)
- New Frontiers of Traumatic Brain Injury Management (Deadline: 31 August 2021)
- Ion Channels in Sperm Physiology 2.0 (Deadline: 31 August 2021)
- Cancer Cell Invasion and Metastases 2.0 (Deadline: 31 August 2021)
- Molecular Approaches for Understanding Dengue Disease (Deadline: 31 August 2021)
- The Intriguing Sigma-1 and Sigma-2 Receptors and Their Potential Therapeutic Roles (Deadline: 31 August 2021)
- Molecular Research on Inherited Metabolic Disorders (Deadline: 31 August 2021)
- Arteriogenesis and Therapeutic Angiogenesis (Deadline: 1 September 2021)
- Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges 2.0 (Deadline: 1 September 2021)
- Cell and Molecular Interactions in Blood Vessels 2021 (Deadline: 1 September 2021)
- The Role of Extracellular Vesicles in the Diagnosis of Cancer (Deadline: 10 September 2021)
- Calcium Mishandling, Inflammation, microRNAs and Their Role in the Adverse Cardiovascular Remodelling (Deadline: 10 September 2021)
- Cellular and Molecular Targets in Acute Ischemic Stroke (Deadline: 15 September 2021)
- The Mode of Actions of the Current Point-of-Care Treatments for Osteoarthritis of the Knee (Deadline: 15 September 2021)
- Molecular Biology of Selenium in Health and Disease (Deadline: 15 September 2021)
- Molecular Research on Inflammatory Skin Diseases (Deadline: 20 September 2021)
- The Key Role of Molecular Diagnostics in Predictive, Preventive and Personalised (3P) Medicine (Deadline: 30 September 2021)
- Advances and Perspectives in Epigenetics and microRNA in Rheumatic Diseases (Deadline: 30 September 2021)
- Herpesviruses and Their Host Cells: EBV- and KSHV-Associated Diseases (Deadline: 30 September 2021)
- Oxidative Stress and Lung Injury (Deadline: 30 September 2021)
- Therapeutic Potential of Targeting Connexins in Managing Disease Onset and Progression (Deadline: 30 September 2021)
- Molecular Decision Making in the Treatment of Colorectal Liver Metastases (Deadline: 30 September 2021)
- Understanding Traumatic Brain Injury: Mechanisms and Therapeutic Targets 3.0 (Deadline: 30 September 2021)
- Pathogenesis and Molecular Treatment Strategies of Diabetic Neuropathy 2.0 (Deadline: 30 September 2021)
- Molecular Research on Emerging Mosquito-Transmitted RNA Viruses 3.0 (Deadline: 30 September 2021)
- Head and Neck Cancers 3.0: Diagnostics, Prognostic Biomarkers and Therapeutic Advances for Primary Tumors and Metastasis (Deadline: 30 September 2021)
- Targeted Cancer Therapy and Mechanisms of Resistance 2.0 (Deadline: 30 September 2021)
- Angiogenesis in Disease (Deadline: 30 September 2021)
- Molecular Biology of Age-Related Macular Degeneration (AMD) 3.0 (Deadline: 30 September 2021)
- Transcriptional Therapy and Nucleic Acid-Based Therapeutics: From Molecular Targets to Preclinical Studies (Deadline: 30 September 2021)
- Zebrafish as an Experimental Model for Metabolic Disease: From Morphology to Therapy the Key Role of Translational Research in Biomedicine (Deadline: 30 September 2021)
- Neuro-Plastic Mechanisms of Pain and Addiction (Deadline: 30 September 2021)
- Targeted Gene Therapy of Cancer (Deadline: 30 September 2021)
- OMICS for Metabolic Mysfunctions (Deadline: 30 September 2021)
- Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer – Illumination of a Vision 3.0 (Deadline: 30 September 2021)
- Role of Bioactive Molecules on Neuroprotection, Oxidative Stress and Neuroinflammation Modulation (Deadline: 30 September 2021)
- Intercellular and Intracellular Communication in Human Health and Disease 2.0 (Deadline: 30 September 2021)
- Molecular Research on Celiac Disease (Deadline: 30 September 2021)
- Gene Expression and Molecular Targets of Oral Cancer and Periodontal Diseases (Deadline: 30 September 2021)
- Tumor Microenvironment and Its Actors: Are Ion Channels Relevant? (Deadline: 30 September 2021)
- From Molecular Mechanisms to Biomarkers of Physical Frailty and Sarcopenia (Deadline: 30 September 2021)
- Inherited Disorders in Neurotransmitters: A Molecular, Cellular and Systemic Perspective (Deadline: 30 September 2021)
- Aging and Risk Factors in Cardiovascular Disease: Cellular, Molecular and Epigenetic Insights (Deadline: 30 September 2021)
- Proteomic Investigations in Nephrology (Deadline: 30 September 2021)
- Epigenetics in Metabolic and Neurological Disorders 2.0 (Deadline: 30 September 2021)
- Biomolecular Characterization of Brain Gliomas and Molecular Alterations Caused by Therapy (Deadline: 30 September 2021)
- Glycobiology-Based Drug Development (Deadline: 30 September 2021)
- Molecular and Cellular Pathogenesis of Fatty Liver Disease and Its Progression (Deadline: 30 September 2021)
- Molecular, Cellular and Systemic Signature of Microglia 2.0 (Deadline: 30 September 2021)
- Transgenic Mice in Human Diseases: Insights from Molecular Research 2.0 (Deadline: 30 September 2021)
- Sarcomere Function in Health and Disease (Deadline: 30 September 2021)
- Cost–Benefit Evaluation in Decision-Making and Psychiatry: Cellular and Molecular Mechanisms (Deadline: 30 September 2021)
- Molecular Recognition in Protein and Peptide Nanotechnology (Deadline: 30 September 2021)
- New Advance in Breast Cancer (Deadline: 30 September 2021)
- Advances in Stem Cell Research for Future Therapies and In Vitro Disease Modelling (Deadline: 30 September 2021)
- Human and Animal Monocytes and Macrophages in Homeostasis and Disease 2.0 (Deadline: 30 September 2021)
- Novel MSC Perspectives: From Cell Regulation to Tissue Regeneration 3.0 (Deadline: 30 September 2021)
- Innovation through Tradition: The Current Challenges in Cancer Treatment (Deadline: 30 September 2021)
- Molecular Research of Migraine: From Pathogenesis to Treatment (Deadline: 30 September 2021)
- New Advances in RNA Interference (Deadline: 30 September 2021)
- Kinase Signal Transduction 2021 (Deadline: 30 September 2021)
- Inhibition of DNA Repair Enzymes as a Valuable Pharmaceutical Approach 2.0 (Deadline: 30 September 2021)
- Mechanisms and Implications of Cellular Expression and Secretion of Coagulation Proteins (Deadline: 30 September 2021)
- Endocannabinoids, Cannabinoids and Psychiatry: Biological Mechanisms 2.0 (Deadline: 30 September 2021)
- Nanotechnology in Cancer Treatment 3.0 (Deadline: 30 September 2021)
- Smart Biomaterials in Tissue Regeneration (Deadline: 30 September 2021)
- Anti-aging: Molecular Mechanisms and Rejuvenation Strategies (Deadline: 30 September 2021)
- Inflammatory Bowel Diseases: Pathogenesis and Future Developments (Deadline: 30 September 2021)
- The Role of Norepinephrine in Neuroprotection (Deadline: 1 October 2021)
- New Trends in Three-Dimensional Model Systems for Regenerative and Pharmacological Approaches (Deadline: 1 October 2021)
- Aquatic Organisms as Disease Models, Sources of Therapeutics, and Pollution Markers (Deadline: 1 October 2021)
- Molecular Research and Treatment of Skin Diseases (Deadline: 15 October 2021)
- Molecular Research on Stress Response and Ocular Homeostasis 2.0 (Deadline: 15 October 2021)
- Natural Killer Cells and Immunotherapy (Deadline: 20 October 2021)
- Molecular and Tissue Engineering Approaches in Musculoskeletal Regenerative Medicine 3.0 (Deadline: 20 October 2021)
- Advances in Research on Spinal Cord Injury (Deadline: 20 October 2021)
- Molecular Mechanisms in Pancreatic Cancer (Deadline: 30 October 2021)
- Recent Research on Diabetes Mellitus and Its Complications (Deadline: 30 October 2021)
- Molecular Imaging in Nanomedical Research 2.0 (Deadline: 31 October 2021)
- Inherited Retinal Diseases: How Can We Move Forward in Understanding and Treating Them 2.0 (Deadline: 31 October 2021)
- Electroporation and Electrochemotherapy in Cancer (Deadline: 31 October 2021)
- Vasculitis (Deadline: 31 October 2021)
- Metabesity and Tissue Regeneration: New Therapies for Emerging Challenges (Deadline: 31 October 2021)
- Molecular Advances in Lung Diseases (Deadline: 31 October 2021)
- Role of Drosophila in Human Disease Research 2.0 (Deadline: 31 October 2021)
- Diabetes and Dementia (Deadline: 31 October 2021)
- Pathways and Molecular Targets in Prostate Cancer: From Basic Research to 4P Medicine (Deadline: 31 October 2021)
- Fatty Acids and Inflammation: From Biochemistry to Human Evidence (Deadline: 31 October 2021)
- Regulatory Role of PPARs in the Disease 2.0 (Deadline: 31 October 2021)
- Chemical Regulation of Gap Junction Channels and Hemichannels 2.0 (Deadline: 31 October 2021)
- The Role of Oxidative Stress and Epithelium-Derived Cytokines in Atopic Dermatitis (Deadline: 31 October 2021)
- The Role of Toll-Like Receptor Signalling in Sterile Inflammation and Autoimmunity (Deadline: 31 October 2021)
- Novel Molecular Targets in Cardiovascular Diseases (Deadline: 31 October 2021)
- Omics of Male (In)Fertility (Deadline: 31 October 2021)
- Connexin and Pannexin Signaling in Health and Disease 2.0 (Deadline: 31 October 2021)
- Pathogenesis and Treatment of Cutaneous Lymphoma (Deadline: 31 October 2021)
- Molecular Research on Rett Syndrome and Related Disorders: From the Past Towards the Future 2.0 (Deadline: 31 October 2021)
- The Future of Cartilage Repair in Complex Biological Situations 2.0 (Deadline: 31 October 2021)
- Focal Therapy and Oncology: State of Play in 2021 (Deadline: 31 October 2021)
- Molecular Mechanisms on Blood-Brain Barrier (BBB) (Deadline: 31 October 2021)
- Changing Paradigms in Inflammatory Bowel Diseases (Deadline: 31 October 2021)
- The Kinase Inhibitors in Genetic Diseases (Deadline: 31 October 2021)
- Neuronal and Synaptic Involvement in Multiple Sclerosis: From Molecular Mechanisms to Novel Biomarkers (Deadline: 31 October 2021)
- Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics 2.0 (Deadline: 31 October 2021)
- Cisplatin in Cancer Therapy: Molecular Mechanisms of Action 3.0 (Deadline: 31 October 2021)
- The Role of MicroRNAs, tRNA Fragments, and Circular RNAs in Leukemia (Deadline: 31 October 2021)
- Advances in Molecular Mechanism of Head and Neck Cancer (Deadline: 31 October 2021)
- Pathogenesis of Pregnancy-Related Complications 3.0 (Deadline: 1 November 2021)
- Scientific Discoveries Supporting Theories in Science: From Thinking to Practice (Deadline: 10 November 2021)
- Role of Reactive Oxygen Species in Tumorigenesis (Deadline: 30 November 2021)
- Exposome and Omics (Deadline: 30 November 2021)
- Retinal Degeneration: From Pathophysiology to Therapeutic Approaches 3.0 (Deadline: 30 November 2021)
- Liver Damage and Repair 2.0 (Deadline: 30 November 2021)
- MicroRNA in Cardiac Health and Disease (Deadline: 30 November 2021)
- Biogenesis and Functional Roles of Lysosomes: Their Implications for the Pathogenesis and Therapy of Human Diseases 2.0 (Deadline: 30 November 2021)
- Telomere Homeostasis in Ageing Related Pathologies (Deadline: 30 November 2021)
- Role of Polymorphic Variation in Non-coding DNA in Predicting the Risk and Progression of Disease (Deadline: 30 November 2021)
- Molecular Mechanisms of Ovarian Cancer Development and Metastasis 3.0 (Deadline: 30 November 2021)
- Dual Targeting as a Strategy to Counteract Chronic Diseases (Deadline: 30 November 2021)
- Disease Modeling with Tissue-Specific Stem Cells or Organoid (Deadline: 30 November 2021)
- Molecular Links between Periodontitis and Systemic Diseases (Deadline: 30 November 2021)
- Natural Bioactive Compounds to Promote Cardiovascular Health (Deadline: 30 November 2021)
- New Applications in the Diagnosis and Therapy of Diseases (Deadline: 30 November 2021)
- Recent Advances in Antithrombotic Agents (Deadline: 30 November 2021)
- Crosstalk between Circadian Rhythm and Diseases 2.0 (Deadline: 30 November 2021)
- MicroRNAs and Stem Cells 3.0 (Deadline: 30 November 2021)
- Advances and Challenges in Biomolecular Radiation Research 2.0 (Deadline: 30 November 2021)
- Epigenetics of Non-Transmissible Diseases 2.0 (Deadline: 30 November 2021)
- Molecular Factors of Intellectual Disability Syndromes (Deadline: 30 November 2021)
- Glioblastoma 2.0 (Deadline: 30 November 2021)
- Whole Joint Philosophy for the Treatment of Early Osteoarthritis: Cellular and Molecular Perspectives (Deadline: 3 December 2021)
- Molecular Research on Acute Lymphoblastic Leukemia 2.0 (Deadline: 10 December 2021)
- Telomeres and Human Disease (Deadline: 17 December 2021)
- Renin-Angiotensin-Aldosterone System in Pathologies (Deadline: 21 December 2021)
- The Role of Fibrinolytic System in Health and Disease 2.0 (Deadline: 31 December 2021)
- Yeast Models and Molecular Mechanisms of Neurodegenerative Diseases 2021 (Deadline: 31 December 2021)
- Molecular Regulators In Obesity and Diabetes (Deadline: 31 December 2021)
- An Application of Modern Machine Learning-Based Approaches for the De Novo Drug Design (Deadline: 31 December 2021)
- Natural Killer and NKT Cells 3.0 (Deadline: 31 December 2021)
- Neuroprotective Strategies 2021 (Deadline: 31 December 2021)
- Neuroinfectiology: Molecular and Cellular Mechanisms of Neurotropic Virus Infection 3.0 (Deadline: 31 December 2021)
- Regulation and Physiopathology of Gut Barrier (Deadline: 31 December 2021)
- Molecular and Genetic Mechanism of Cataracts (Deadline: 31 December 2021)
- Sepsis: From Molecular Mechanisms, Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 December 2021)
- Approaches for Genome Editing Using Viral Vectors of Adenovirus and Lentivirus (Deadline: 31 December 2021)
- Mechanistic Insights into Skeletal Muscle Aging (Deadline: 31 December 2021)
- New Insights into Psoriasis (Deadline: 31 December 2021)
- Integrin Signaling and Human Pathologies 2021 (Deadline: 31 December 2021)
- Calcification in Human Pathology 2.0 (Deadline: 31 December 2021)
- Common Molecular Mechanisms in Embryonic Development (Deadline: 31 December 2021)
- Recent Advances of Proteomics Applied to Cancer and Human Diseases 2.0 (Deadline: 31 December 2021)
- Melanoma Cell Signaling Pathways (Deadline: 31 December 2021)
- Cardiotoxicity of Anticancer Treatments (Deadline: 31 January 2022)
- Transglutaminase Diseases, from the Experimental laboratory to Human Pathology Applications 2.0 (Deadline: 31 January 2022)
Topical Collections
Following topical collections within this section are currently open for submissions:
